Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zoetis Inc Class A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,721,616
  • Shares Outstanding, K 480,450
  • Annual Sales, $ 5,307 M
  • Annual Income, $ 864,000 K
  • 36-Month Beta 0.99
  • Price/Sales 7.97
  • Price/Cash Flow 30.93
  • Price/Book 20.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.77
  • Number of Estimates 6
  • High Estimate 0.79
  • Low Estimate 0.75
  • Prior Year 0.69
  • Growth Rate Est. (year over year) +11.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.30 +2.74%
on 12/10/18
95.59 -6.17%
on 11/13/18
-5.58 (-5.86%)
since 11/09/18
3-Month
86.40 +3.81%
on 10/11/18
96.57 -7.12%
on 11/01/18
+1.45 (+1.64%)
since 09/11/18
52-Week
70.20 +27.76%
on 02/09/18
96.57 -7.12%
on 11/01/18
+17.92 (+24.97%)
since 12/11/17

Most Recent Stories

More News
Zoetis (ZTS) Down 0.4% Since Last Earnings Report: Can It Rebound?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZTS : 89.41 (+0.55%)
Is Zoetis (ZTS) Outperforming Other Medical Stocks This Year?

Is (ZTS) Outperforming Other Medical Stocks This Year?

ZTS : 89.41 (+0.55%)
SmarTrend Watching for Potential Rebound in Shares of Zoetis Inc After 2.27% Loss

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $90.13 to a high of $92.70. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $90.32 on...

ZTS : 89.41 (+0.55%)
Zoetis Inc Set to Possibly Rebound After Yesterday's Selloff of 1.05%

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $92.63 to a high of $94.99. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $93.61 on...

ZTS : 89.41 (+0.55%)
Can Zoetis (ZTS) Stock Continue to Grow Earnings?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Zoetis (ZTS).

ZTS : 89.41 (+0.55%)
Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View

Zoetis (ZTS) beats both earnings and sales estimates in the third quarter of 2018. The company also updates its 2018 outlook.

MRK : 77.42 (+0.03%)
LLY : 114.60 (+0.45%)
ZTS : 89.41 (+0.55%)
BMY : 52.56 (-0.04%)
Zoetis (ZTS) Q3 Earnings & Revenues Surpass Estimates

Zoetis beats earnings and sales estimates in the third quarter of 2018.

ZTS : 89.41 (+0.55%)
Zoetis: 3Q Earnings Snapshot

PARSIPPANY, N.J. (AP) _ Zoetis Inc. (ZTS) on Thursday reported third-quarter profit of $347 million.

ZTS : 89.41 (+0.55%)
Zoetis Announces Third Quarter 2018 Results

--Reports Adjusted Net Income of $403 Million, or Adjusted Diluted EPS of $0.83, for Third Quarter 2018

ZTS : 89.41 (+0.55%)
Should You Buy Zoetis (ZTS) Ahead of Earnings?

Zoetis (ZTS) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

ZTS : 89.41 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade ZTS with:

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

2nd Resistance Point 90.60
1st Resistance Point 89.76
Last Price 89.41
1st Support Level 87.69
2nd Support Level 86.46

See More

52-Week High 96.57
Last Price 89.41
Fibonacci 61.8% 86.50
Fibonacci 50% 83.38
Fibonacci 38.2% 80.27
52-Week Low 70.20

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar